Urothelial Carcinoma

• CLINICAL_TRIALS trial_result · 2007-11-06
  Clinical Trial Update: 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen [Phase 2]

  Phase 2 trial completed evaluating gemcitabine monotherapy as second-line treatment for urothelial carcinoma after cisplatin-based therapy.

• CLINICAL_TRIALS trial_result · 2006-07-19
  Clinical Trial Update: A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium [Phase 2]

  This update describes the completed Phase 2 trial of pemetrexed (ALIMTA) in locally advanced or metastatic urothelial carcinoma.

• CLINICAL_TRIALS trial_result · 2006-07-19
  Clinical Trial Update: A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium [Phase 2]

  A Phase 2 study evaluated ALIMTA (pemetrexed) plus gemcitabine in locally advanced or metastatic urothelial carcinoma and has completed the …